SATT Sud-Est

SATT Sud-Est
Name	SATT Sud-Est
Formation	2012
Type	Technology transfer company
Headquarters	Marseille
Region served	Provence-Alpes-Côte d'Azur, Occitanie

SATT Sud-Est is a French technology transfer company established to accelerate the maturation and commercialization of academic research from institutions across Provence-Alpes-Côte d'Azur and Occitanie. It works with universities, research organizations, hospitals, and incubators to protect intellectual property, create start-ups, and license technologies to industry. The organization interacts with multiple stakeholders in the innovation ecosystem including public research agencies, venture capital firms, regional authorities, and multinational corporations.

History

SATT Sud-Est was created in the context of the French Initiative d'Excellence and the investments promoted by Agence Nationale de la Recherche, aligning with reforms affecting ComUE structures and PRES reorganizations that followed the 2013 French higher education law. Its formation involved partners such as Aix-Marseille Université, Université de Montpellier, Université Côte d'Azur, CNRS, INSERM, and INRAE, reflecting a regional consolidation similar to precedents set by SATT Lutech and SATT Ouest Valorisation. Early governance drew on experiences from Centre national de la recherche scientifique, Institut Pasteur, and CEA spin-off policies, and benefitted from funding frameworks connected to Programme d'Investissements d'Avenir and European Regional Development Fund. Key milestones included structuring technology transfer agreements with CHU de Montpellier, negotiating IP portfolios with Institut Méditerranéen du Risque, and establishing incubation links with Silicon Valley-style accelerators and French incubators like Pépinières d'entreprises models.

Mission and Objectives

SATT Sud-Est aims to bridge laboratory discoveries and marketable products by supporting patent prosecution, prototype development, and company creation, mirroring missions of organizations such as KTH Innovation and Imperial Innovations. Its objectives include increasing licensing revenues akin to Oxford University Innovation, fostering start-up creation comparable to Cambridge Enterprise, and enhancing regional competitiveness similar to initiatives by Bpifrance and Région Provence-Alpes-Côte d'Azur. The company focuses on sectors represented by its partners, including biomedical fields related to AP-HM, agri-food innovations linked with INRAE, digital technologies connected to IRT SystemX-style projects, and energy transitions comparable to ADEME programs.

Organization and Governance

The governance model involves a board with representatives from founding institutions such as Aix-Marseille Université, Université de Montpellier, Université Côte d'Azur, CNRS, INSERM, and regional authorities like Région Occitanie. Operational management includes technology scouting teams, IP lawyers, and business developers, paralleling structures at Yozma Group-inspired organizations and corporate venture arms like TotalEnergies's corporate development. The company interacts with legal frameworks shaped by INPI practices, contractual norms seen at CEA, and compliance considerations related to European Commission state aid guidelines. Advisory boards have featured experts with backgrounds at Sanofi, Servier, GSK, Novartis, and L'Oréal for sector-specific guidance.

Investment and Funding Activities

SATT Sud-Est deploys internal funds to mature technologies and leverages co-investment from actors like Bpifrance, European Investment Bank, regional venture funds such as Sofimac, and corporate partners including Thales and Schneider Electric. Investment strategies resemble those of Innocells and Johnson & Johnson Innovation with staged funding for proof-of-concept, prototyping, and regulatory pathway support referencing benchmarks set by European Innovation Council. It negotiates licensing deals and equity stakes in start-ups, coordinates with business angels from networks like France Angels, and supports access to accelerator programs similar to Station F and Euratechnologies.

Notable Projects and Innovations

Projects supported have spanned medtech innovations originating from university hospitals like CHU de Nice and CHU Timone, agro-biotech developments tied to INRAE research units, and software tools developed in collaboration with Mines ParisTech-affiliated labs. Innovations include diagnostic devices reflecting translational pathways akin to those at Institut Curie, regenerative medicine projects with links to European Society for Biomaterials networks, and environmental technologies resonant with CIRAD-related work. Spin-offs supported have entered cohorts associated with French Tech ecosystems and competed for awards such as the i-Lab national competition.

Partnerships and Collaborations

SATT Sud-Est maintains partnerships with universities like Aix-Marseille Université, Université de Montpellier, and Université Côte d'Azur, research organizations including CNRS and INSERM, clinical centers such as AP-HM and CHU de Montpellier, and regional development agencies like Région Provence-Alpes-Côte d'Azur and Région Occitanie. It collaborates with incubators and accelerators such as Pépinières d'entreprises, Station F, and Euratechnologies, and engages with industry partners including Sanofi, Thales, Schneider Electric, L'Oréal, and Airbus for transfer and licensing opportunities. International links extend to networks like European Institute of Innovation and Technology and EUREKA clusters.

Impact and Metrics

Impact is measured by indicators similar to those used by AUTM and AURPI: number of patents filed with INPI, licenses executed, start-ups created, jobs generated, and follow-on investment attracted from sources like Bpifrance and European Investment Bank. Reported outcomes align with regional economic development targets pursued by Région Provence-Alpes-Côte d'Azur and Région Occitanie and contribute to innovation rankings that reference benchmarks such as European Innovation Scoreboard and Bloomberg Innovation Index. Metrics include collaborations with clinical trials networks similar to ECRIN and participation in grant consortia funded by Horizon 2020 and Horizon Europe.

Category:Technology transfer organizations in France Category:Research commercialization